Joe Southerland, DPM
Foot & Ankle Surgery · Jasper, GANPI 1659321107
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Ossio Inc at 56.6% of the total.
Across 43 payments — averaging $142.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ossio Inc$3K
- Treace Medical Concepts, Inc.$2K
- Smith+Nephew$352
- Orthofix Medical, Inc.$72
- Amgen$69
- Stryker$52
- plus $286 from 10 others
What the payments were for
- Consulting fees$3,37555%
- Travel & lodging$1,49024%
- Food & beverage$1,27821%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ossio Inc | 3 | $3,475 |
| Treace Medical Concepts, Inc. | 10 | $1,837 |
| Smith+Nephew | 8 | $352 |
| Orthofix Medical, Inc. | 4 | $72 |
| Amgen(2 entities) | 3 | $69 |
| Stryker(2 entities) | 2 | $52 |
| Bioventus LLC | 2 | $52 |
| Zimmer Biomet | 1 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Tactile Systems Technology Inc | 1 | $29 |
| Paratek Pharmaceuticals, Inc. | 2 | $26 |
| Integra Lifesciences Corporation | 1 | $26 |
| Abbott | 1 | $24 |
| IBSA Pharma Inc. | 1 | $23 |
| Solventum Corporation | 1 | $20 |
| KCI USA, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LAPIPLASTY SYSTEM 1$1,490
- Stravix$138
- STRAVIX MESH$138
- Grafix$138
- TMC NANOPLASTY SYSTEM$119
How this compares
$6,143 in reported general payments places this provider in the 75th percentile of 239 foot & ankle surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 49 | $300 |
| Methylprednisolone | 34 | $199 |
| Doxycycline Hyclate | 22 | $147 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $90 |
| Meloxicam | 18 | $40 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Jasper
- Robert WeinsteinFayetteville$394K
- Jason BariteauAtlanta$199K
- Scott RomanPeachtree City$118K
- Jeffrey FlashForest Park$114K
- Mickey StappThomson$110K
- David MurphyWaycross$55K
- Rishin KadakiaAtlanta$53K
- Javan BassLithonia$43K
- Bhavin MehtaAtlanta$43K
- Corbett ThigpenAugusta$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.